Veritable’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-150,154
| Closed | -$24.9M | – | 432 |
|
|
2023
Q2 | $24.9M | Buy |
150,154
+209
| +0.1% | +$33.7K | 0.38% | 27 |
|
|
2023
Q1 | $23.2M | Sell |
149,945
-15,233
| -9% | -$2.46M | 0.38% | 27 |
|
|
2022
Q4 | $29.2M | Sell |
165,178
-2,646
| -2% | -$457K | 0.5% | 23 |
|
|
2022
Q3 | $27.4M | Sell |
167,824
-2,581
| -2% | -$437K | 0.53% | 21 |
|
|
2022
Q2 | $30.2M | Buy |
170,405
+458
| +0.3% | +$81.6K | 0.55% | 21 |
|
|
2022
Q1 | $30.1M | Sell |
169,947
-2,578
| -1% | -$439K | 0.46% | 24 |
|
|
2021
Q4 | $29.5M | Sell |
172,525
-69
| -0% | -$11.3K | 0.44% | 28 |
|
|
2021
Q3 | $27.9M | Sell |
172,594
-1,524
| -0.9% | -$260K | 0.45% | 29 |
|
|
2021
Q2 | $28.7M | Buy |
174,118
+1,230
| +0.7% | +$204K | 0.46% | 30 |
|
|
2021
Q1 | $28.4M | Buy |
172,888
+855
| +0.5% | +$138K | 0.48% | 27 |
|
|
2020
Q4 | $27.1M | Sell |
172,033
-8,178
| -5% | -$1.21M | 0.5% | 28 |
|
|
2020
Q3 | $26.8M | Buy |
180,211
+8,905
| +5% | +$1.32M | 0.54% | 25 |
|
|
2020
Q2 | $24.1M | Sell |
171,306
-7,929
| -4% | -$1.16M | 0.52% | 25 |
|
|
2020
Q1 | $23.5M | Sell |
179,235
-28,528
| -14% | -$4.05M | 0.57% | 25 |
|
|
2019
Q4 | $30.3M | Sell |
207,763
-7,918
| -4% | -$1.07M | 0.56% | 22 |
|
|
2019
Q3 | $27.9M | Buy |
215,681
+2,151
| +1% | +$283K | 0.55% | 25 |
|
|
2019
Q2 | $29.7M | Sell |
213,530
-510
| -0.2% | -$70.6K | 0.59% | 24 |
|
|
2019
Q1 | $29.9M | Sell |
214,040
-2,167
| -1% | -$290K | 0.6% | 24 |
|
|
2018
Q4 | $27.9M | Sell |
216,207
-5,038
| -2% | -$703K | 0.64% | 22 |
|
|
2018
Q3 | $30.6M | Sell |
221,245
-4,922
| -2% | -$654K | 0.61% | 22 |
|
|
2018
Q2 | $27.4M | Sell |
226,167
-3,765
| -2% | -$470K | 0.58% | 22 |
|
|
2018
Q1 | $29.5M | Buy |
229,932
+4,342
| +2% | +$587K | 0.63% | 23 |
|
|
2017
Q4 | $31.5M | Sell |
225,590
-22,128
| -9% | -$3.08M | 0.63% | 23 |
|
|
2017
Q3 | $32.2M | Sell |
247,718
-2,157
| -0.9% | -$286K | 0.68% | 21 |
|
|
2017
Q2 | $33.1M | Sell |
249,875
-4,998
| -2% | -$638K | 0.75% | 19 |
|
|
2017
Q1 | $31.7M | Sell |
254,873
-3,251
| -1% | -$388K | 0.76% | 19 |
|
|
2016
Q4 | $29.7M | Buy |
258,124
+1,741
| +0.7% | +$201K | 0.73% | 19 |
|
|
2016
Q3 | $30.3M | Buy |
256,383
+7,063
| +3% | +$857K | 0.76% | 19 |
|
|
2016
Q2 | $30.2M | Sell |
249,320
-8,186
| -3% | -$930K | 0.77% | 19 |
|
|
2016
Q1 | $27.9M | Buy |
257,506
+1,601
| +0.6% | +$166K | 0.73% | 20 |
|
|
2015
Q4 | $26.3M | Buy |
255,905
+5,320
| +2% | +$535K | 0.72% | 22 |
|
|
2015
Q3 | $23.4M | Buy |
250,585
+2,586
| +1% | +$250K | 0.69% | 22 |
|
|
2015
Q2 | $24.2M | Sell |
247,999
-156,839
| -39% | -$15.7M | 0.66% | 20 |
|
|
2015
Q1 | $40.7M | Sell |
404,838
-1,495
| -0.4% | -$152K | 0.85% | 18 |
|
|
2014
Q4 | $42.5M | Sell |
406,333
-19,382
| -5% | -$2.04M | 0.88% | 19 |
|
|
2014
Q3 | $45.4M | Sell |
425,715
-3,811
| -0.9% | -$395K | 0.96% | 18 |
|
|
2014
Q2 | $44.9M | Sell |
429,526
-12,418
| -3% | -$1.26M | 0.94% | 19 |
|
|
2014
Q1 | $43.4M | Sell |
441,944
-1,055
| -0.2% | -$97.8K | 0.94% | 18 |
|
|
2013
Q4 | $40.6M | Buy |
442,999
+1,471
| +0.3% | +$136K | 0.89% | 20 |
|
|
2013
Q3 | $38.3M | Buy |
441,528
+24,259
| +6% | +$2.18M | 0.9% | 19 |
|
|
2013
Q2 | $35.8M | Buy |
+417,269
| New | +$35.4M | 0.86% | 20 |
|
Other funds holding JNJ
Veritable's JNJ Position: Q3 2023 in Review
Veritable sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 150,154 shares — an estimated $24.9M sold.
Veritable first reported a position in JNJ in Q2 2013 and held it in 41 quarters. The position peaked at $45.4M in Q3 2014. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.
- Veritable reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
- Veritable sold 150,154 Johnson & Johnson shares in Q3 2023, an estimated $24.9M.
- Veritable first reported a position in Johnson & Johnson in Q2 2013 and held it in 41 quarters.
- Veritable's Johnson & Johnson position peaked at $45.4M in Q3 2014.
- 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.
Based on Veritable's 13F filing for Q3 2023.